(-)-epigallocatechin 3-gallate increases expression ISO ZFP36L2 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of ZFP36L2 mRNA CTD PMID:16084531 (-)-epigallocatechin 3-gallate multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZFP36L2 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO Zfp36l2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP36L2 mRNA CTD PMID:36331819 17beta-estradiol affects expression ISO Zfp36l2 (Mus musculus) 6480464 Estradiol affects the expression of ZFP36L2 mRNA CTD PMID:15598610 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ZFP36L2 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ZFP36L2 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Estradiol results in decreased expression of ZFP36L2 mRNA CTD PMID:19484750 17beta-estradiol decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Estradiol results in decreased expression of ZFP36L2 mRNA CTD PMID:19167446 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO ZFP36L2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of ZFP36L2 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ZFP36L2 mRNA CTD PMID:30621213 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ZFP36L2 mRNA CTD PMID:19770486 and PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of ZFP36L2 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ZFP36L2 mRNA CTD PMID:22298810 and PMID:33387578 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Zfp36l2 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of ZFP36L2 mRNA CTD PMID:17982090 2-butoxyethanol increases expression ISO Zfp36l2 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of ZFP36L2 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of ZFP36L2 mRNA CTD PMID:30851411 3',5'-cyclic AMP increases abundance ISO Zfp36l2 (Mus musculus) 6480464 ZFP36L2 protein mutant form results in increased abundance of Cyclic AMP CTD PMID:24830504 3,4-methylenedioxymethamphetamine decreases expression ISO Zfp36l2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZFP36L2 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of ZFP36L2 mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36L2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZFP36L2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Zfp36l2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ZFP36L2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZFP36L2 mRNA CTD PMID:28628672 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ZFP36L2 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO ZFP36L2 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZFP36L2 mRNA CTD PMID:22079614 amphotericin B decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of ZFP36L2 mRNA CTD PMID:28534445 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA CTD PMID:33854195 Benoxacor decreases expression ISO Zfp36l2 (Mus musculus) 6480464 benoxacor results in decreased expression of ZFP36L2 mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ZFP36L2 mRNA CTD PMID:27195522 benzo[a]pyrene decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ZFP36L2 mRNA CTD PMID:20106945 and PMID:21632981 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ZFP36L2 mRNA CTD PMID:25181051 bisphenol A affects methylation ISO Zfp36l2 (Mus musculus) 6480464 bisphenol A affects the methylation of ZFP36L2 promoter CTD PMID:27334623 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ZFP36L2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ZFP36L2 mRNA CTD PMID:30816183 and PMID:35192832 bisphenol F multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36L2 mRNA CTD PMID:28628672 buta-1,3-diene decreases expression ISO Zfp36l2 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of ZFP36L2 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of ZFP36L2 mRNA CTD PMID:19167457 cadmium atom increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Cadmium results in increased expression of ZFP36L2 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZFP36L2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZFP36L2 mRNA CTD PMID:35301059 caffeine decreases phosphorylation ISO ZFP36L2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of ZFP36L2 protein CTD PMID:35688186 carbamazepine affects expression ISO ZFP36L2 (Homo sapiens) 6480464 Carbamazepine affects the expression of ZFP36L2 mRNA CTD PMID:25979313 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA CTD PMID:33854195 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of ZFP36L2 mRNA CTD PMID:27905518 chlorpyrifos decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of ZFP36L2 mRNA CTD PMID:27905518 chlorpyrifos increases expression ISO Zfp36l2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ZFP36L2 mRNA CTD PMID:30621213 choline multiple interactions ISO Zfp36l2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP36L2 gene CTD PMID:20938992 cisplatin multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of ZFP36L2 mRNA CTD PMID:21858171 cisplatin decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ZFP36L2 mRNA CTD PMID:27594783 cisplatin decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Cisplatin results in decreased expression of ZFP36L2 mRNA CTD PMID:21151649 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ZFP36L2 mRNA CTD PMID:22023808 cisplatin affects response to substance ISO ZFP36L2 (Homo sapiens) 6480464 ZFP36L2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clofibrate decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Clofibrate results in decreased expression of ZFP36L2 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of ZFP36L2 mRNA CTD PMID:19320972 and PMID:19376846 colforsin daropate hydrochloride decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Colforsin results in decreased expression of ZFP36L2 mRNA CTD PMID:15967414 crotonaldehyde decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 2-butenal results in decreased expression of ZFP36L2 mRNA CTD PMID:20471460 CU-O LINKAGE decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 cupric oxide results in decreased expression of ZFP36L2 mRNA CTD PMID:22077320 cyclosporin A decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ZFP36L2 mRNA CTD PMID:20106945 and PMID:25562108 cypermethrin increases expression ISO Zfp36l2 (Mus musculus) 6480464 cypermethrin results in increased expression of ZFP36L2 mRNA CTD PMID:29020013 dexamethasone increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Dexamethasone results in increased expression of ZFP36L2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36L2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZFP36L2 mRNA CTD PMID:28628672 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ZFP36L2 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ZFP36L2 mRNA CTD PMID:24893172 dicrotophos increases expression ISO ZFP36L2 (Homo sapiens) 6480464 dicrotophos results in increased expression of ZFP36L2 mRNA CTD PMID:28302478 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of ZFP36L2 mRNA CTD PMID:36653537 dioxygen increases expression ISO Zfp36l2 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of ZFP36L2 mRNA CTD PMID:24205000 disodium selenite increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of ZFP36L2 mRNA CTD PMID:18175754 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ZFP36L2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases response to substance ISO ZFP36L2 (Homo sapiens) 6480464 ZFP36L2 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 doxorubicin affects response to substance ISO ZFP36L2 (Homo sapiens) 6480464 ZFP36L2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ZFP36L2 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO Zfp36l2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of ZFP36L2 mRNA CTD PMID:35436446 ethanol multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZFP36L2 mRNA CTD PMID:29432896 Ethylenethiourea decreases expression EXP 6480464 Ethylenethiourea results in decreased expression of ZFP36L2 mRNA CTD PMID:27905518 Ethylenethiourea decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Ethylenethiourea results in decreased expression of ZFP36L2 mRNA CTD PMID:27905518 fenamidone increases expression ISO Zfp36l2 (Mus musculus) 6480464 fenamidone results in increased expression of ZFP36L2 mRNA CTD PMID:27029645 folic acid multiple interactions ISO Zfp36l2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP36L2 gene CTD PMID:20938992 FR900359 decreases phosphorylation ISO ZFP36L2 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of ZFP36L2 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ZFP36L2 mRNA CTD PMID:22061828 and PMID:33387578 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA CTD PMID:33854195 hydrogen peroxide affects expression ISO ZFP36L2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of ZFP36L2 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO Zfp36l2 (Mus musculus) 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA CTD PMID:33854195 indometacin multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36L2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZFP36L2 mRNA CTD PMID:28628672 irinotecan decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Irinotecan metabolite results in decreased expression of ZFP36L2 mRNA and Irinotecan results in decreased expression of ZFP36L2 mRNA CTD PMID:15956246 L-methionine multiple interactions ISO Zfp36l2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP36L2 gene CTD PMID:20938992 lead diacetate increases expression ISO Zfp36l2 (Mus musculus) 6480464 lead acetate results in increased expression of ZFP36L2 mRNA CTD PMID:21829687 leflunomide increases expression ISO ZFP36L2 (Homo sapiens) 6480464 leflunomide results in increased expression of ZFP36L2 mRNA CTD PMID:28988120 menadione affects expression ISO ZFP36L2 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of ZFP36L2 mRNA CTD PMID:20044591 methylmercury chloride increases expression ISO ZFP36L2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of ZFP36L2 mRNA CTD PMID:28001369 N-acetyl-L-cysteine increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Acetylcysteine results in increased expression of ZFP36L2 mRNA CTD PMID:16084531 nickel sulfate increases expression ISO ZFP36L2 (Homo sapiens) 6480464 nickel sulfate results in increased expression of ZFP36L2 mRNA CTD PMID:18651567 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of ZFP36L2 mRNA CTD PMID:23665939 paclitaxel affects response to substance ISO ZFP36L2 (Homo sapiens) 6480464 ZFP36L2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 panobinostat multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFP36L2 mRNA CTD PMID:27188386 panobinostat increases expression ISO ZFP36L2 (Homo sapiens) 6480464 panobinostat results in increased expression of ZFP36L2 mRNA CTD PMID:26272509 paracetamol decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ZFP36L2 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ZFP36L2 mRNA CTD PMID:33387578 paracetamol increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ZFP36L2 mRNA CTD PMID:26690555 perfluorooctane-1-sulfonic acid multiple interactions ISO Zfp36l2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP36L2 mRNA CTD PMID:36331819 phenobarbital affects expression ISO Zfp36l2 (Mus musculus) 6480464 Phenobarbital affects the expression of ZFP36L2 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZFP36L2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Zfp36l2 (Mus musculus) 6480464 pirinixic acid results in increased expression of ZFP36L2 mRNA CTD PMID:18301758 and PMID:18445702 piroxicam multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of ZFP36L2 mRNA CTD PMID:21858171 potassium chromate increases expression ISO ZFP36L2 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of ZFP36L2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZFP36L2 mRNA CTD PMID:22079256 rac-lactic acid increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of ZFP36L2 mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ZFP36L2 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of ZFP36L2 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of ZFP36L2 mRNA CTD PMID:25895662 silver atom decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Silver results in decreased expression of ZFP36L2 mRNA CTD PMID:26014281 silver(0) decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Silver results in decreased expression of ZFP36L2 mRNA CTD PMID:26014281 sodium arsenite decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ZFP36L2 mRNA CTD PMID:25879800 sodium arsenite increases expression ISO Zfp36l2 (Mus musculus) 6480464 sodium arsenite results in increased expression of ZFP36L2 mRNA CTD PMID:36209798 Soman increases expression EXP 6480464 Soman results in increased expression of ZFP36L2 mRNA CTD PMID:19281266 tamoxifen affects expression ISO Zfp36l2 (Mus musculus) 6480464 Tamoxifen affects the expression of ZFP36L2 mRNA CTD PMID:20937368 tetrachloroethene increases expression ISO Zfp36l2 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of ZFP36L2 mRNA CTD PMID:28973375 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA CTD PMID:33854195 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ZFP36L2 mRNA CTD PMID:23411599 and PMID:34492290 thioacetamide increases methylation EXP 6480464 Thioacetamide results in increased methylation of ZFP36L2 promoter CTD PMID:27914986 titanium dioxide decreases expression ISO Zfp36l2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of ZFP36L2 mRNA CTD PMID:29264374 torcetrapib increases expression ISO ZFP36L2 (Homo sapiens) 6480464 torcetrapib results in increased expression of ZFP36L2 mRNA CTD PMID:23228038 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ZFP36L2 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of ZFP36L2 mRNA CTD PMID:24935251 trichostatin A affects expression ISO ZFP36L2 (Homo sapiens) 6480464 trichostatin A affects the expression of ZFP36L2 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFP36L2 mRNA CTD PMID:27188386 trichostatin A increases expression ISO ZFP36L2 (Homo sapiens) 6480464 trichostatin A results in increased expression of ZFP36L2 mRNA CTD PMID:24935251 and PMID:26272509 troglitazone decreases expression ISO Zfp36l2 (Mus musculus) 6480464 troglitazone results in decreased expression of ZFP36L2 mRNA CTD PMID:28973697 tungsten decreases expression ISO Zfp36l2 (Mus musculus) 6480464 Tungsten results in decreased expression of ZFP36L2 mRNA CTD PMID:30912803 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of ZFP36L2 mRNA CTD PMID:24136188 valproic acid affects expression ISO Zfp36l2 (Mus musculus) 6480464 Valproic Acid affects the expression of ZFP36L2 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO ZFP36L2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFP36L2 mRNA CTD PMID:27188386 valproic acid increases expression ISO ZFP36L2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ZFP36L2 mRNA CTD PMID:24383497 more ... valproic acid affects expression ISO ZFP36L2 (Homo sapiens) 6480464 Valproic Acid affects the expression of ZFP36L2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO ZFP36L2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ZFP36L2 mRNA CTD PMID:24935251 and PMID:29154799 vincaleukoblastine affects response to substance ISO ZFP36L2 (Homo sapiens) 6480464 ZFP36L2 protein affects the susceptibility to Vinblastine CTD PMID:16217747 zoledronic acid increases expression ISO ZFP36L2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of ZFP36L2 mRNA CTD PMID:20977926